In PIONEER 1 and 9 where semaglutide was used as monotherapy, patients were previously treated with diet and exercise, or an OAD (in PIONEER 9) that required a wash-out period
When analyzed by individual agents, liraglutide demonstrated the strongest protective association (OR = 0.13, 95% CI: 0.050.32, p = 0.0001), followed by dulaglutide (OR = 0.26, 95% CI: 0.11-0.60, p = 0.01) and semaglutide (OR = 0.27, 95% CI: 0.080.98, p = 0.046), all of which were statistically significant
These conversations are often more productive than written appeals and give you the opportunity to make the clinical case for why Medicaid should cover weight loss shots for your specific patient
Saxenda Starter Pack Unboxing Unboxing your Saxenda starter pack: what's included, how to use the pen, first doses, and what to expect when beginning liraglutide treatment
Growth hormone and aging: A challenging controversy